Atlantic Coastal Acquisition Corp. II financial data

Symbol
ACAB, ACABU, ACABW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6 St Johns Lane, Floor 5, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 23, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 57.2 % +65.8%
Debt-to-equity -148 % -30.4%
Return On Equity 8.82 %
Return On Assets -6.38 % -411%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 0 USD

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.24M USD -7.81%
Nonoperating Income (Expense) 1.01M USD -88.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.23M USD -118%
Income Tax Expense (Benefit) 210K USD -88.4%
Net Income (Loss) Attributable to Parent -1.44M USD -129%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 237K USD -89.4%
Assets, Current 277K USD -88.7%
Assets 7.9M USD -79.5%
Accrued Liabilities, Current 469K USD -62.3%
Liabilities, Current 7.31M USD +14.4%
Liabilities 17.8M USD +5.44%
Retained Earnings (Accumulated Deficit) -17.4M USD -17.5%
Stockholders' Equity Attributable to Parent -17.4M USD -17.5%
Liabilities and Equity 7.9M USD -79.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -264K USD -171%
Net Cash Provided by (Used in) Financing Activities -29.7M USD
Net Cash Provided by (Used in) Investing Activities 29.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -254K USD -161%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 237K USD -89.4%
Deferred Tax Assets, Valuation Allowance 687K USD +76.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Cash and Cash Equivalents, Period Increase (Decrease) 331K USD
Deferred Tax Assets, Gross 687K USD +76.8%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%